Evidence map›Paper›PMID 33936051›Full record

ArticleFrontiers in immunology2021

Revisit of Optimal Donor Number Estimation in the Hong Kong Bone Marrow Donor Registry.

Jenny Chung Yee Ho, Stephen Kwok Fan Cheung, Zhongyi Lui, Ivan Wing Hong Tang, Wanling Yang, Patrick Ip, Cheuk Kwong Lee, Derek Middleton, Janette Siu Yin Kwok

Abstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jenny Chung Yee HoDivision of Transplantation and Immunogenetics, Queen Mary Hospital, Hong Kong, Hong Kong.
Stephen Kwok Fan CheungDivision of Transplantation and Immunogenetics, Queen Mary Hospital, Hong Kong, Hong Kong.
Zhongyi LuiDepartment of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong, Hong Kong.
Ivan Wing Hong TangDivision of Transplantation and Immunogenetics, Queen Mary Hospital, Hong Kong, Hong Kong.
Wanling YangDepartment of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong, Hong Kong.
Patrick IpDepartment of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong, Hong Kong.
Cheuk Kwong LeeHong Kong Red Cross Blood Transfusion Services, Hong Kong, Hong Kong.
Derek MiddletonTransplant Immunology, Royal Liverpool Hospital, Liverpool, United Kingdom.
Janette Siu Yin KwokDivision of Transplantation and Immunogenetics, Queen Mary Hospital, Hong Kong, Hong Kong.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High resolution typing of the HLA-DPB1 locus for patient who requested for hematopoietic stem cell transplantation (HSCT) workup has recently become mandatory by the National Marrow Donor Program (NMDP) in order to facilitate matching between donors and recipients for better outcomes. The likelihood of identifying HLA matched donors in Hong Kong, on top of the existing HLA-A, -B, -C, and -DRB1 loci, is revisited in this study. HLA-A, -B, -C, -DRB1 and -DPB1 genotypes of 5,266 volunteer unrelated Chinese donors from the Hong Kong Bone Marrow Donor Registry (HKBMDR), were included in this study. Matching models were employed to determine the matching probabilities for 10/10(DPB1) and 9/10(DPB1) HLA match. The matching probabilities are 20% at 10/10(DPB1) HLA match and 55% at 9/10(DPB1) match, based on the existing 130,000 donors in the HKBMDR. The likelihoods of match become 27% and 65% respectively, by increasing the registry to 250,000. However, if DPB T-cell-epitope (TCE) model is considered in the matching, the probability will increase to 46% at 10/10 DPB1 permissive mismatching. Our findings provide vital information about the future planning on the targeted recruitment size, HLA typing and search strategies of the donor registry and arose the transplant physicians' acceptability to 9/10(DBP1) or 10/10(DBP1) HLA match. Nevertheless, the marrow donor registry has planned for increasing the registry size and bringing down the age of recruited donors which will ultimately enhance patient outcome.

Indexed as

Bone Marrow TransplantationGenotypeDirected Tissue DonationEpitopes, T-LymphocyteGene FrequencyHistocompatibilityHistocompatibility TestingHLA-DP beta-ChainsHong KongHumansPolymorphism, GeneticRegistriesTissue DonorsEpitopes, T-LymphocyteHLA-DPB1 antigenHLA-DP beta-ChainsallelesChinesefrequency haplotypesHLA antigensmatching probability

Identifiers

PMID33936051
PMCPMC8085527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.